All Articles

The appointment of Robert Tidd is more than a new hire; it's a calculated move to master AI governance and redefine trust in a complex digital landscape.

A $170M recapitalization of Lone Peak Dental Group isn't just finance. It's a test of whether private credit can expand vital care for underserved kids.

Oregon's Tillamook isn't just winning awards; it's executing a masterclass in product innovation and brand strategy to challenge dairy giants.

Known for its athletic tape, KT is making a strategic leap into the crowded OTC pain relief aisle. Is this a brilliant brand extension or a risky bet?

Strong Q2 results reveal how metallurgical tweaks and plant optimizations in Latin America are driving record output and lifting Mineros' 2026 outlook.

Canon's new AI for CT scanners promises near-photon-counting quality. Is this a true leap forward for diagnostics or a clever stopgap in a competitive market?

Nanoscope's revolutionary MCO-010 gene therapy offers hope to millions with retinal disease. A new partnership with Catalent is the critical final step.

Associated Capital Group's rising book value isn't just a number. It's a signal of a focused strategy executing in a dynamic alternative investment market.

Amid a CCO transition, the acclaimed regional bank installs a veteran leader and reinforces its team, signaling a proactive strategy for growth and stability.

Boston-based Assail launches Sidewinder, an AI that autonomously finds exploits, fixes its own mistakes, and learns. Is this the end of traditional pentesting?

Pediatrica Health's $28M Series B aims to fix a broken system. With investors betting on 'equitable access,' is this the future of child healthcare?

Dave Inc. promotes Gopi Kuchimanchi to CTO, a strategic move reinforcing its reliance on proprietary AI to navigate a competitive neobank market.

Kanawha Scales & Systems acquires Strack Scale Service, extending its national reach and deploying a unique M&A model that makes new employees instant owners.

The Vetster-PetSmart Canadian partnership embeds virtual vets into retail, signaling a major shift in pet care delivery and market strategy. What does it mean?

Precinmac's acquisition of Advance Mfg. is more than a purchase; it's a calculated move to build a one-stop shop for mission-critical components.

A new partnership brings autonomous AI agents to the lab, promising to slash drug development timelines. But can these 'AI scientists' be trusted with our future medicines?

Christina Fisher's appointment is more than a new CFO. It’s a strategic move to steer UL's massive endowment and global safety ambitions. What does it signal?

XBOW's new AWS Security Competency isn't just a badge. It marks a critical shift to autonomous, AI-driven defense against AI-accelerated threats.

Lumanity's aggressive, science-based emissions targets are not just for the planet—they are a calculated move to win business in the demanding biopharma sector.

As the US sports betting market explodes, critical questions about its societal impact remain unanswered. Arnold Ventures is funding 12 studies to fill the data void.